Literature DB >> 18259195

Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin.

N Byts1, A Samoylenko, T Fasshauer, M Ivanisevic, L Hennighausen, H Ehrenreich, A-L Sirén.   

Abstract

The transcription factors signal transducer and activator of transcription 5a and 5b (Stat5) are activated by the neuroprotective and neurotrophic cytokines, erythropoietin (EPO) and growth hormone (GH). Here, we show a dissociation of the intracellular pathway mediating the protective effect of EPO against glutamate toxicity from that needed for its neurotrophic activity using hippocampal neuronal cultures from Stat5a/b-knockout (Stat5(-/-)) mouse fetuses. Both pretreatment and post-treatment with EPO counteracted glutamate-induced cell death in Stat5(+/+) and Stat5(-/-) neurons. Acute pharmacological inhibition of Janus kinase 2 (JAK2)/Stat signalling had no effect on EPO neuroprotection, whereas inhibition of phosphatidylinositol-3' kinase (PI3K)/Akt pathway abolished the protective effect of EPO in both Stat5(+/+) and Stat5(-/-) neurons. GH effectively protected Stat5(+/+) cells against glutamate toxicity but had no effect in Stat5(-/-) neurons or in Stat5(+/+) neurons treated with JAK2/Stat or PI3K inhibitor. EPO and GH stimulated neurite outgrowth and branching of Stat5(+/+) neurons by activating PI3K/Akt signalling but had no trophic effect in Stat5(-/-) cells. We conclude that in hippocampal neurons, Stat5 is not required for neuroprotection by EPO but is together with Akt essential for its neurotrophic activity. Both Stat5 and Akt are needed for neuroprotective and neurotrophic signalling of GH in neurons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18259195     DOI: 10.1038/cdd.2008.1

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  39 in total

1.  Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis.

Authors:  Claudia Bartels; Kira Späte; Henning Krampe; Hannelore Ehrenreich
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

2.  Neurotrophic paths in the treatment of depression.

Authors:  Shawn Hayley; Hymie Anisman
Journal:  J Psychiatry Neurosci       Date:  2013-09       Impact factor: 6.186

3.  Effects of erythropoietin in murine-induced pluripotent cell-derived panneural progenitor cells.

Authors:  Nils Offen; Johannes Flemming; Hares Kamawal; Ruhel Ahmad; Wanja Wolber; Christian Geis; Holm Zaehres; Hans R Schöler; Hannelore Ehrenreich; Albrecht M Müller; Anna-Leena Sirén
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

4.  Erythropoietin neuroprotection with traumatic brain injury.

Authors:  Lucido L Ponce; Jovany Cruz Navarro; Osama Ahmed; Claudia S Robertson
Journal:  Pathophysiology       Date:  2012-03-14

5.  Signal transducer and activator of transcription-5 mediates neuronal apoptosis induced by inhibition of Rac GTPase activity.

Authors:  Trisha R Stankiewicz; F Alexandra Loucks; Emily K Schroeder; Marja T Nevalainen; Kenneth L Tyler; Klaus Aktories; Ron J Bouchard; Daniel A Linseman
Journal:  J Biol Chem       Date:  2012-02-29       Impact factor: 5.157

Review 6.  Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?

Authors:  Carla Cerami Hand; Michael Brines
Journal:  J Investig Med       Date:  2011-10       Impact factor: 2.895

7.  Erythropoietin: a multimodal neuroprotective agent.

Authors:  Nadiya Byts; Anna-Leena Sirén
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

8.  Stiff person-syndrome IgG affects presynaptic GABAergic release mechanisms.

Authors:  Christian Werner; Holger Haselmann; Andreas Weishaupt; Klaus V Toyka; Claudia Sommer; Christian Geis
Journal:  J Neural Transm (Vienna)       Date:  2014-07-03       Impact factor: 3.575

Review 9.  Survival and proliferative roles of erythropoietin beyond the erythroid lineage.

Authors:  Constance Tom Noguchi; Li Wang; Heather M Rogers; Ruifeng Teng; Yi Jia
Journal:  Expert Rev Mol Med       Date:  2008-12-01       Impact factor: 5.600

10.  Hypoxic ischemic brain injury: Potential therapeutic interventions for the future.

Authors:  Aaron J Muller; Jeremy D Marks
Journal:  Neoreviews       Date:  2014-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.